Simon Hambidge
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 44 | 2026 | 1468 | 3.170 |
Why?
| | Influenza Vaccines | 24 | 2026 | 551 | 2.920 |
Why?
| | Vaccines | 19 | 2025 | 407 | 2.630 |
Why?
| | Influenza, Human | 18 | 2026 | 630 | 2.110 |
Why?
| | Immunization | 8 | 2021 | 402 | 1.970 |
Why?
| | Immunization Programs | 10 | 2022 | 221 | 1.520 |
Why?
| | Pediatric Obesity | 10 | 2024 | 604 | 1.500 |
Why?
| | Adverse Drug Reaction Reporting Systems | 10 | 2023 | 80 | 1.250 |
Why?
| | Infant | 55 | 2026 | 9820 | 1.070 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 10 | 2017 | 96 | 1.040 |
Why?
| | Child Health Services | 5 | 2022 | 196 | 0.990 |
Why?
| | Measles-Mumps-Rubella Vaccine | 9 | 2021 | 47 | 0.980 |
Why?
| | Parents | 8 | 2021 | 1439 | 0.920 |
Why?
| | Child, Preschool | 49 | 2026 | 11511 | 0.890 |
Why?
| | Chickenpox Vaccine | 9 | 2021 | 74 | 0.860 |
Why?
| | Terminology as Topic | 2 | 2017 | 244 | 0.850 |
Why?
| | Attitude to Health | 3 | 2017 | 451 | 0.840 |
Why?
| | Reminder Systems | 3 | 2026 | 174 | 0.820 |
Why?
| | Cohort Studies | 38 | 2024 | 5809 | 0.760 |
Why?
| | Vaccination Coverage | 4 | 2026 | 98 | 0.750 |
Why?
| | Managed Care Programs | 5 | 2017 | 140 | 0.740 |
Why?
| | Counseling | 3 | 2017 | 395 | 0.710 |
Why?
| | Female | 97 | 2026 | 75814 | 0.700 |
Why?
| | Government Programs | 1 | 2021 | 27 | 0.690 |
Why?
| | Colorado | 20 | 2026 | 4599 | 0.670 |
Why?
| | Immunization Schedule | 5 | 2021 | 202 | 0.670 |
Why?
| | United States | 47 | 2026 | 15298 | 0.670 |
Why?
| | Information Storage and Retrieval | 3 | 2020 | 118 | 0.640 |
Why?
| | Humans | 123 | 2026 | 141284 | 0.640 |
Why?
| | Vaccines, Combined | 5 | 2020 | 49 | 0.630 |
Why?
| | Child | 51 | 2025 | 22390 | 0.630 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1395 | 0.620 |
Why?
| | Abortion, Spontaneous | 4 | 2025 | 116 | 0.620 |
Why?
| | Adolescent | 48 | 2025 | 22116 | 0.620 |
Why?
| | Whooping Cough | 5 | 2014 | 55 | 0.610 |
Why?
| | Pregnancy | 28 | 2026 | 7035 | 0.580 |
Why?
| | Male | 74 | 2026 | 70140 | 0.580 |
Why?
| | Language | 4 | 2017 | 310 | 0.580 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2025 | 408 | 0.570 |
Why?
| | Preventive Health Services | 2 | 2013 | 154 | 0.570 |
Why?
| | Population Surveillance | 9 | 2017 | 481 | 0.560 |
Why?
| | Seizures, Febrile | 5 | 2017 | 22 | 0.550 |
Why?
| | Pneumococcal Vaccines | 3 | 2022 | 138 | 0.550 |
Why?
| | Anemia, Sickle Cell | 2 | 2011 | 267 | 0.550 |
Why?
| | Wounds and Injuries | 4 | 2008 | 917 | 0.530 |
Why?
| | Urban Population | 5 | 2016 | 482 | 0.520 |
Why?
| | School Health Services | 4 | 2014 | 233 | 0.510 |
Why?
| | Vulnerable Populations | 2 | 2009 | 170 | 0.500 |
Why?
| | Safety-net Providers | 4 | 2021 | 124 | 0.480 |
Why?
| | Dental Caries | 1 | 2017 | 173 | 0.470 |
Why?
| | Seizures | 3 | 2014 | 441 | 0.470 |
Why?
| | Oral Health | 1 | 2017 | 137 | 0.460 |
Why?
| | Young Adult | 30 | 2026 | 13727 | 0.460 |
Why?
| | Chickenpox | 2 | 2020 | 81 | 0.450 |
Why?
| | Incidence | 18 | 2024 | 2809 | 0.440 |
Why?
| | Emergency Service, Hospital | 6 | 2014 | 2210 | 0.440 |
Why?
| | Body Mass Index | 6 | 2024 | 2390 | 0.440 |
Why?
| | Office Visits | 2 | 2007 | 94 | 0.430 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2014 | 9 | 0.430 |
Why?
| | Adult | 42 | 2026 | 39319 | 0.430 |
Why?
| | Retrospective Studies | 36 | 2024 | 16447 | 0.420 |
Why?
| | Hospitalization | 6 | 2020 | 2264 | 0.410 |
Why?
| | Case-Control Studies | 14 | 2025 | 3577 | 0.400 |
Why?
| | Product Surveillance, Postmarketing | 6 | 2022 | 68 | 0.400 |
Why?
| | Primary Health Care | 6 | 2021 | 1757 | 0.400 |
Why?
| | Self Report | 4 | 2026 | 859 | 0.400 |
Why?
| | Bronchiolitis | 1 | 2014 | 84 | 0.390 |
Why?
| | Pertussis Vaccine | 2 | 2011 | 24 | 0.390 |
Why?
| | Electronic Health Records | 7 | 2026 | 1129 | 0.390 |
Why?
| | Infant, Newborn | 19 | 2025 | 6270 | 0.390 |
Why?
| | Genes, MHC Class II | 1 | 2012 | 75 | 0.380 |
Why?
| | Weight Reduction Programs | 2 | 2024 | 117 | 0.370 |
Why?
| | Papillomavirus Vaccines | 1 | 2016 | 317 | 0.370 |
Why?
| | Delivery of Health Care | 2 | 2017 | 948 | 0.370 |
Why?
| | Health Promotion | 2 | 2023 | 749 | 0.360 |
Why?
| | Treatment Refusal | 2 | 2010 | 96 | 0.360 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2014 | 184 | 0.360 |
Why?
| | Rotavirus Vaccines | 3 | 2022 | 42 | 0.350 |
Why?
| | Health Services Research | 2 | 2012 | 401 | 0.350 |
Why?
| | Vaccines, Inactivated | 4 | 2012 | 68 | 0.330 |
Why?
| | Health Personnel | 1 | 2017 | 727 | 0.330 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 47 | 0.330 |
Why?
| | Communication Barriers | 1 | 2011 | 115 | 0.320 |
Why?
| | Meningococcal Vaccines | 3 | 2017 | 64 | 0.320 |
Why?
| | Immunization, Secondary | 3 | 2025 | 92 | 0.310 |
Why?
| | Risk Assessment | 12 | 2020 | 3522 | 0.310 |
Why?
| | Urban Health | 2 | 2006 | 95 | 0.300 |
Why?
| | Case Management | 1 | 2009 | 65 | 0.300 |
Why?
| | Middle Aged | 25 | 2026 | 34658 | 0.290 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2022 | 91 | 0.280 |
Why?
| | Health Services Accessibility | 4 | 2011 | 1030 | 0.280 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 15 | 0.280 |
Why?
| | Cross-Sectional Studies | 8 | 2026 | 5653 | 0.280 |
Why?
| | Congenital Abnormalities | 3 | 2017 | 105 | 0.270 |
Why?
| | Anaphylaxis | 3 | 2021 | 103 | 0.270 |
Why?
| | Insurance, Health | 3 | 2012 | 296 | 0.270 |
Why?
| | Pediatrics | 2 | 2006 | 1102 | 0.260 |
Why?
| | Poverty | 5 | 2021 | 527 | 0.260 |
Why?
| | Child Care | 1 | 2007 | 33 | 0.250 |
Why?
| | Community Health Services | 2 | 2010 | 232 | 0.250 |
Why?
| | Accident Prevention | 1 | 2006 | 25 | 0.250 |
Why?
| | Measles | 2 | 2020 | 48 | 0.250 |
Why?
| | Internet | 1 | 2011 | 683 | 0.250 |
Why?
| | Child Development | 1 | 2011 | 496 | 0.250 |
Why?
| | Risk | 9 | 2017 | 903 | 0.240 |
Why?
| | Herpes Zoster | 2 | 2020 | 319 | 0.240 |
Why?
| | Stillbirth | 2 | 2024 | 74 | 0.240 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2017 | 27 | 0.240 |
Why?
| | Chorioamnionitis | 2 | 2017 | 45 | 0.230 |
Why?
| | International Classification of Diseases | 2 | 2020 | 141 | 0.230 |
Why?
| | Aluminum | 2 | 2022 | 44 | 0.220 |
Why?
| | Narration | 1 | 2026 | 68 | 0.220 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2025 | 38 | 0.220 |
Why?
| | Developmental Disabilities | 2 | 2020 | 288 | 0.220 |
Why?
| | Athletic Injuries | 3 | 2006 | 527 | 0.220 |
Why?
| | Prenatal Care | 2 | 2017 | 301 | 0.210 |
Why?
| | Mass Screening | 2 | 2015 | 1309 | 0.210 |
Why?
| | Patient Acceptance of Health Care | 5 | 2024 | 874 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 130 | 0.200 |
Why?
| | Seasons | 6 | 2024 | 547 | 0.200 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2014 | 99 | 0.200 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 3 | 2022 | 254 | 0.200 |
Why?
| | Smallpox Vaccine | 1 | 2022 | 24 | 0.190 |
Why?
| | Multivariate Analysis | 4 | 2015 | 1505 | 0.190 |
Why?
| | Cataplexy | 1 | 2022 | 8 | 0.190 |
Why?
| | Bell Palsy | 1 | 2022 | 9 | 0.190 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2021 | 291 | 0.190 |
Why?
| | Narcolepsy | 1 | 2022 | 25 | 0.180 |
Why?
| | Eczema | 1 | 2022 | 69 | 0.180 |
Why?
| | Thrombocytopenia | 2 | 2022 | 206 | 0.180 |
Why?
| | Healthcare Disparities | 2 | 2021 | 674 | 0.180 |
Why?
| | Pregnancy Outcome | 5 | 2025 | 453 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 108 | 0.180 |
Why?
| | Motivation | 2 | 2017 | 600 | 0.170 |
Why?
| | Disease Outbreaks | 1 | 2024 | 424 | 0.170 |
Why?
| | Premature Birth | 4 | 2024 | 363 | 0.170 |
Why?
| | Fever | 2 | 2013 | 310 | 0.170 |
Why?
| | Pregnancy Complications | 3 | 2017 | 577 | 0.170 |
Why?
| | Risk Factors | 8 | 2020 | 10490 | 0.170 |
Why?
| | Databases, Factual | 4 | 2025 | 1449 | 0.160 |
Why?
| | Focus Groups | 2 | 2014 | 565 | 0.160 |
Why?
| | Vaccination Refusal | 1 | 2021 | 70 | 0.160 |
Why?
| | Mumps | 1 | 2020 | 24 | 0.160 |
Why?
| | Diphtheria-Tetanus Vaccine | 2 | 2009 | 5 | 0.160 |
Why?
| | Australia | 1 | 2020 | 287 | 0.160 |
Why?
| | Age Distribution | 4 | 2010 | 396 | 0.150 |
Why?
| | Sex Distribution | 4 | 2010 | 381 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 908 | 0.150 |
Why?
| | Tetanus Toxoid | 2 | 2015 | 36 | 0.150 |
Why?
| | Regression Analysis | 4 | 2015 | 1013 | 0.140 |
Why?
| | Community Health Centers | 2 | 2009 | 63 | 0.140 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 13 | 0.140 |
Why?
| | Aged | 8 | 2025 | 24836 | 0.130 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2017 | 30 | 0.130 |
Why?
| | Diagnosis, Oral | 1 | 2017 | 8 | 0.130 |
Why?
| | Caregivers | 1 | 2026 | 940 | 0.130 |
Why?
| | Paint | 1 | 2017 | 9 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1336 | 0.130 |
Why?
| | Syncope | 1 | 2017 | 58 | 0.130 |
Why?
| | Dentists | 1 | 2017 | 21 | 0.130 |
Why?
| | Confidence Intervals | 3 | 2021 | 328 | 0.130 |
Why?
| | Infant, Small for Gestational Age | 2 | 2015 | 103 | 0.130 |
Why?
| | Fluorides | 1 | 2017 | 49 | 0.130 |
Why?
| | Preconception Care | 1 | 2017 | 48 | 0.130 |
Why?
| | Prevalence | 4 | 2020 | 2795 | 0.130 |
Why?
| | Age Factors | 5 | 2017 | 3295 | 0.130 |
Why?
| | Logistic Models | 3 | 2015 | 2098 | 0.130 |
Why?
| | Drug Hypersensitivity | 1 | 2017 | 94 | 0.120 |
Why?
| | Phosphates | 1 | 2017 | 178 | 0.120 |
Why?
| | Educational Status | 2 | 2023 | 463 | 0.120 |
Why?
| | Registries | 4 | 2010 | 2205 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 1 | 2017 | 113 | 0.120 |
Why?
| | Time Factors | 9 | 2022 | 6951 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 370 | 0.110 |
Why?
| | Sex Factors | 2 | 2021 | 2055 | 0.110 |
Why?
| | Causality | 2 | 2006 | 131 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 893 | 0.110 |
Why?
| | Health Care Surveys | 2 | 2007 | 561 | 0.110 |
Why?
| | Parental Consent | 1 | 2014 | 27 | 0.110 |
Why?
| | Fruit | 1 | 2015 | 146 | 0.110 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2014 | 28 | 0.100 |
Why?
| | Vegetables | 1 | 2015 | 161 | 0.100 |
Why?
| | Computer Simulation | 3 | 2013 | 1009 | 0.100 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2014 | 69 | 0.100 |
Why?
| | Pandemics | 4 | 2024 | 1655 | 0.100 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.100 |
Why?
| | Reimbursement Mechanisms | 1 | 2014 | 82 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2009 | 2069 | 0.100 |
Why?
| | Patient Navigation | 1 | 2015 | 98 | 0.100 |
Why?
| | Social Environment | 1 | 2015 | 294 | 0.100 |
Why?
| | Drug Eruptions | 1 | 2013 | 29 | 0.100 |
Why?
| | Health Policy | 1 | 2016 | 385 | 0.100 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 108 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2017 | 364 | 0.100 |
Why?
| | Rotavirus Infections | 2 | 2012 | 39 | 0.100 |
Why?
| | Viral Vaccines | 1 | 2014 | 107 | 0.100 |
Why?
| | Comprehension | 1 | 2014 | 182 | 0.100 |
Why?
| | Utilization Review | 2 | 2009 | 41 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5222 | 0.090 |
Why?
| | Maternal Age | 2 | 2023 | 128 | 0.090 |
Why?
| | Health Services | 1 | 2013 | 116 | 0.090 |
Why?
| | Intussusception | 1 | 2012 | 27 | 0.090 |
Why?
| | Models, Theoretical | 2 | 2013 | 582 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1311 | 0.090 |
Why?
| | Health Education | 1 | 2015 | 360 | 0.090 |
Why?
| | Parenting | 1 | 2015 | 319 | 0.090 |
Why?
| | Electronic Mail | 1 | 2011 | 65 | 0.090 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 207 | 0.090 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.090 |
Why?
| | Database Management Systems | 1 | 2011 | 51 | 0.090 |
Why?
| | Health Care Costs | 1 | 2014 | 417 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 656 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2929 | 0.080 |
Why?
| | Asthma | 1 | 2022 | 1911 | 0.080 |
Why?
| | Qualitative Research | 1 | 2017 | 1519 | 0.080 |
Why?
| | Hepatitis A Vaccines | 1 | 2009 | 15 | 0.080 |
Why?
| | Diphtheria Toxoid | 1 | 2009 | 13 | 0.080 |
Why?
| | Altitude | 1 | 2014 | 475 | 0.080 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 43 | 0.080 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 5948 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 669 | 0.070 |
Why?
| | Acetaminophen | 1 | 2011 | 263 | 0.070 |
Why?
| | Patient Readmission | 1 | 2014 | 698 | 0.070 |
Why?
| | Drug Evaluation | 1 | 2008 | 79 | 0.070 |
Why?
| | Medicaid | 2 | 2009 | 450 | 0.070 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2008 | 5 | 0.070 |
Why?
| | Gastroenteritis | 1 | 2009 | 67 | 0.070 |
Why?
| | Platelet Count | 1 | 2008 | 88 | 0.070 |
Why?
| | Ambulatory Care Facilities | 2 | 2009 | 245 | 0.070 |
Why?
| | Splenectomy | 1 | 2008 | 61 | 0.070 |
Why?
| | Acute Disease | 2 | 2008 | 1005 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 257 | 0.070 |
Why?
| | House Calls | 1 | 2009 | 144 | 0.070 |
Why?
| | Probability | 1 | 2008 | 307 | 0.070 |
Why?
| | Communicable Disease Control | 1 | 2008 | 86 | 0.070 |
Why?
| | Vaccines, Conjugate | 2 | 2022 | 63 | 0.070 |
Why?
| | Health Surveys | 1 | 2009 | 511 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 367 | 0.060 |
Why?
| | Social Class | 1 | 2008 | 269 | 0.060 |
Why?
| | Domestic Violence | 1 | 2006 | 53 | 0.060 |
Why?
| | Chronic Disease | 2 | 2013 | 1807 | 0.060 |
Why?
| | Cluster Analysis | 2 | 2006 | 518 | 0.060 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2904 | 0.060 |
Why?
| | Skin | 1 | 2011 | 760 | 0.060 |
Why?
| | Patient Dropouts | 1 | 2006 | 65 | 0.060 |
Why?
| | Linear Models | 1 | 2008 | 855 | 0.060 |
Why?
| | Medication Adherence | 1 | 2009 | 510 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 351 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2008 | 1312 | 0.060 |
Why?
| | Disease Progression | 2 | 2014 | 2808 | 0.060 |
Why?
| | Research Design | 2 | 2013 | 1105 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3793 | 0.050 |
Why?
| | Pregnancy Trimester, First | 2 | 2017 | 136 | 0.050 |
Why?
| | Accidents, Home | 1 | 2004 | 33 | 0.050 |
Why?
| | Survival Analysis | 1 | 2008 | 1322 | 0.050 |
Why?
| | Vaccines, Attenuated | 2 | 2017 | 130 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1178 | 0.050 |
Why?
| | Prospective Studies | 4 | 2021 | 7805 | 0.050 |
Why?
| | Hospitals, General | 1 | 2024 | 24 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2366 | 0.050 |
Why?
| | Physicians | 1 | 2012 | 930 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2013 | 592 | 0.050 |
Why?
| | Physicians, Family | 1 | 2005 | 192 | 0.050 |
Why?
| | Public Health Informatics | 1 | 2003 | 9 | 0.050 |
Why?
| | Physician's Role | 1 | 2005 | 218 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2015 | 7948 | 0.050 |
Why?
| | Accidents, Traffic | 1 | 2004 | 191 | 0.050 |
Why?
| | Health Status | 1 | 2008 | 822 | 0.050 |
Why?
| | Family Practice | 1 | 2007 | 440 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1268 | 0.050 |
Why?
| | Benchmarking | 1 | 2024 | 179 | 0.050 |
Why?
| | Respiratory Tract Infections | 1 | 2006 | 388 | 0.050 |
Why?
| | Thigh | 2 | 2013 | 49 | 0.050 |
Why?
| | Odds Ratio | 2 | 2015 | 1057 | 0.040 |
Why?
| | Injections, Intramuscular | 2 | 2013 | 140 | 0.040 |
Why?
| | Arm | 2 | 2013 | 109 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2021 | 83 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 138 | 0.040 |
Why?
| | Algorithms | 2 | 2020 | 1764 | 0.040 |
Why?
| | Myocarditis | 1 | 2021 | 99 | 0.040 |
Why?
| | Systole | 1 | 2020 | 175 | 0.040 |
Why?
| | Pilot Projects | 1 | 2026 | 1820 | 0.040 |
Why?
| | Health Facilities | 1 | 2020 | 83 | 0.040 |
Why?
| | Stroke | 1 | 2009 | 1199 | 0.040 |
Why?
| | Poisson Distribution | 2 | 2011 | 76 | 0.040 |
Why?
| | Antigens | 1 | 2021 | 349 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 374 | 0.040 |
Why?
| | Mass Vaccination | 1 | 2019 | 19 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4080 | 0.040 |
Why?
| | Bias | 2 | 2013 | 208 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 1546 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 511 | 0.040 |
Why?
| | Health Behavior | 2 | 2015 | 784 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 952 | 0.030 |
Why?
| | Exercise | 2 | 2020 | 2113 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2020 | 654 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 337 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2815 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2015 | 26 | 0.030 |
Why?
| | Computers | 1 | 2015 | 68 | 0.030 |
Why?
| | Video Games | 1 | 2015 | 30 | 0.030 |
Why?
| | Demography | 1 | 2015 | 296 | 0.030 |
Why?
| | Television | 1 | 2015 | 71 | 0.030 |
Why?
| | Refugees | 1 | 2015 | 80 | 0.030 |
Why?
| | Vasculitis | 1 | 2014 | 68 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 802 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 86 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1740 | 0.030 |
Why?
| | Family Characteristics | 1 | 2015 | 191 | 0.030 |
Why?
| | Emigrants and Immigrants | 1 | 2015 | 148 | 0.020 |
Why?
| | California | 1 | 2014 | 457 | 0.020 |
Why?
| | Drug Utilization | 1 | 2013 | 166 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2015 | 285 | 0.020 |
Why?
| | Monitoring, Immunologic | 1 | 2011 | 22 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 195 | 0.020 |
Why?
| | Sample Size | 1 | 2011 | 126 | 0.020 |
Why?
| | Schools | 1 | 2014 | 451 | 0.020 |
Why?
| | Family | 1 | 2015 | 677 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 589 | 0.020 |
Why?
| | Safety Management | 1 | 2011 | 126 | 0.020 |
Why?
| | Data Collection | 1 | 2013 | 655 | 0.020 |
Why?
| | Safety | 1 | 2011 | 356 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 94 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 1035 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 771 | 0.020 |
Why?
| | Diet | 1 | 2015 | 1277 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2047 | 0.010 |
Why?
| | Health Care Reform | 1 | 2005 | 109 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1973 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 2005 | 282 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1610 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3345 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 11216 | 0.010 |
Why?
|
|
Hambidge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|